Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg
Miscellaneous Services (Temporary Codes)
Q5109 is a valid 2026 HCPCS code for Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg or just “Injection, ixifi, 10 mg” for short, used in Medical care.
| HCPCS Level II Code Miscellaneous Services (Temporary Codes) |
|
| HCPCS Code | Q5109 |
|---|---|
| Description |
Long description:
Short description: |
| HCPCS Modifier1 | |
| HCPCS Pricing indicator |
51 - Drugs
|
| Multiple pricing indicator |
A - Not applicable as HCPCS priced under one methodology
|
| Coverage code | D - Special coverage instructions apply |
| BETOS2 code | O1E - Other drugs |
| HCPCS Action code | N - No maintenance for this code |
| Type of service | 1 - Medical care |
| Effective date | Effective Jan 01, 2026 |
| Date added | Added Jan 01, 2019 |
| Termination date | Dec 31, 2025 |
| HCPCS Coding Procedures | |
In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.
Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
“NU” identifies the hospital bed as new equipment
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”